에 대한 최신 뉴스 Philip Morris Intl (NYSE:PM) 주식

Philip Morris Intl

Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heatsticks, vapes, and oral nicotine offerings primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI has not only diversified away from smokeable products but also gained a toehold into the US to sell its iQOS heated tobacco product.

The Coca-Cola Co.

Analyst Color

Analyst Ratings

Trading Ideas

뱅크오브아메리카 증권(BofA Securities) 애널리스트인 브라이언 D. 스필레인(Bryan D. Spillane), 리사 K. 르완도프스키(Lisa K. Lewandowski), 피터 T. 갈보(Peter T. Galbo)는 화요일(8일) 잠재적인 경기침체를 대비한 필수소비재 기업에 대한 연구 결과를 발표했다.

경기 침체기에도 시장수익률 상회할 음료, 포장식품, 담배 등 필수소비재 주식은?

wall street ai15

Education

Econ #s

VRTX

2025년 1분기에 가장 성과가 좋았던 S&amp;P 500 주식 다섯 종목은 CVS 헬스(NYSE:CVS), 필립모리스(NYSE:PM), 뉴몬트(NYSE:NEM), 센코라(NYSE:COR), 그리고 버텍스 파마슈티컬스(NASDAQ:VRTX)이며, 이들은 최근 며칠 동안 단지 미미한 하락만 겪었다. 무역 긴장과 경기 침체에 대한 우려로 S&amp;P 500 지수가 10% 급락한 것과는 대조적이다. 

S&amp;P 500 종목 중 2025년 1분기에 강세 보인 5개 주식...랠리 지속될까?

Equities

News

Markets

DLTR

FTAI

Hims & Hers Health, Inc. Class A Common Stock

HIMS

HOOD

NVDA

PHIG

PYPL

SMCI

SOFI

TMUS

월요일(3일) 미국 증시는 도널드 트럼프 대통령이 전면적인 새로운 관세를 발표하면서 급격한 매도세를 보였고, 지난주 손실이 확대되며 모든 주요 섹터가 하락세를 보였다. 

트럼프 관세로 인한 시장 매도세 속 기술 부문 큰 타격...엔비디아·슈퍼마이크로·ARM 급락

Philip Morris International Inc Common Stock

Philip Morris International Inc

Plasmatech Inc

PGIM Rock ETF Trust PGIM S&P 500 Max Buffer ETF - April

Innovator U.S. Equity Power Buffer ETF - March

PREMIER INVESTMENTS LTD by Premier Investments Ltd.

Premier Investments Ltd

Powell Max Limited - Class A Ordinary Shares

Powell Max Ltd

Innovator U.S. Equity Power Buffer ETF - May

Pharmala Biotech Holdings Inc

PROMOTORA AMBIENTAL SAB B by Promotora Ambiental SAB de CV

Promotora Ambiental SAB de CV

PEMBINA PPLNE PFD A SER 7 by Pembina Pipeline Corp.

Pembina Pipeline Corp

PIMCO Mortgage-Backed Securities Active Exchange-Traded Fund

PMB AEROSPACE CORP by PMB Aerospace Corporation

PMB Aerospace Corp

PharmaCyte Biotech Inc

PELOTON MINERALS CORP by Peloton Minerals Corporation

Peloton Minerals Corp

PT MERDEKA COPPER GLD TBK by PT MERDEKA COPPER GOLD TBK

PT Merdeka Copper Gold Tbk

Prospector Metals Corp

PROSPECTOR METALS CORP by PROSPECTOR METALS CORP.

Pro Medicus Ltd

Psychemedics Corp.

PSYCHEMEDICS CORP NEW by Psychemedics Corp.

Psychemedics Corp

PRO MEDICUS LTD U/ADR by Pro Medicus, Ltd.

PT MITRA ADIPERKASA TBK by Pt Mitra Adiperkasa Tbk

PT Mitra Adiperkasa Tbk

PT MITRA ADIPERKASA S/ADR by Pt Mitra Adiperkasa Tbk

PACE MEDICAL INC by Pace Medical, Inc.

PLATEAU MINERAL DEV INC by Plateau Mineral Development, Inc.

Plateau Mineral Development Inc

Sonoran Desert Copper Corp

SONORAN DESERT COPPER CP by SONORAN DESERT COPPER CORP

PHARMA FOODS INTL CO by Pharma Foods International Co., Ltd.

Pharma Foods International Co Ltd

PM&E Inc

Primech Holdings Ltd

PREDICTMEDIX AI INC by PREDICTMEDIX AI INC.

Predictmedix AI Inc

PATRIOT BATTERY METALS by PATRIOT BATTERY METALS INC

Patriot Battery Metals Inc

PIMCO Municipal Income Fund

PGIM Rock ETF Trust PGIM S&P 500 Max Buffer ETF - February

Priveterra Acquisition Corp II Ordinary Shares - Class A

Priveterra Acquisition Corp II

Priveterra Acquisition Corp II Units (1 Ord Class A & 1/2 War)

Priveterra Acquisition Corp II Warrants (02/12/2025)

Perth Mint Gold Token

Perpetual Energy Inc

PRIME MERIDIAN HLDG CO by Prime Meridian Holding Co.

Prime Meridian Holding Co

PERFECT MED HLTH U/ADR by PERFECT MED HEALTH MGMT LTD.

POLOMAR HEALTH SVCS INC by Polomar Health Services, Inc.

Polomar Health Services Inc

PLASMA INNOVATIVE INC by PLASMA INNOVATIVE INC.

Plasma Innovative Inc

PGIM ETF Trust PGIM Municipal Income Opportunities ETF

PMI GROUP INC NEW by PMI Group, Inc. (The)

PMI Group Inc

PT MULTI INDOCITRA ORD by PT Multi Indocitra Tbk

PGIM Rock ETF Trust PGIM S&P 500 Max Buffer ETF - January

PT Merck Tbk

Playmaker Capital Inc Ordinary Shares

PINKMONKEY.COM INC by PinkMonkey.com, Inc.

PinkMonkey.com Inc

Pimco Municipal Income Fund II Common Shares of Beneficial Interest

PIMCO Municipal Income Fund II

Putnam Managed Municipal Income Trust Common Stock

Putnam Managed Municipal Income Trust

PUMA AG RUDOLF DASSLER SP by Puma AG Rudolf Dassler Sport

Puma SE

PEMBINA PIPELINE CORP PFD by Pembina Pipeline Corp.

Pampa Metals Corp Ordinary Shares

PAMPA METALS CORP by Pampa Metals Corporation

Pampa Metals Corp

PREMIUM EXPL INC by Premium Exploration, Inc.

Premium Exploration Inc

BlackRock ETF Trust iShares Prime Money Market ETF

PREMIUM GROUP CO LTD by PREMIUM GROUP CO LTD.

Premium Group Co Ltd

PGIM Rock ETF Trust PGIM S&P 500 Max Buffer ETF - March

Precious Metals and Mining Trust

ProMIS Neurosciences Inc. - Common Shares

ProMIS Neurosciences Inc

Perfect Moment Ltd

PERSEUS MINING LTD ORD by Perseus Mining Ltd

Perseus Mining Ltd

Putnam Municipal Opportunities Trust Common Stock

Putnam Municipal Opportunities Trust

Harbour Energy PLC

Prismo Metals Inc

Polychain Monsters

PRISMONE GROUP INC by PrismOne Group, Inc.

PREMIER PRODUCTS GROUP by Premier Products Group, Inc.

Premier Products Group Inc

Primaris REIT

POP MART INTL UNSP/ADR by Pop Mart International Group Limited

Pop Mart International Group Ltd

PROTEOME SCIENCES PLC by Proteome Sciences PLC

Proteome Sciences PLC

PRIMAL SOLUTIONS INC by Primal Solutions, Inc.

Primal Solutions Inc

PennyMac Mortgage Investment Trust Common Shares of Beneficial Interest

PennyMac Mortgage Investment Trust

PACIFIC METALS CO LTD by Pacific Metals Co., Ltd.

Pacific Metals Co Ltd

PRECIOUS MTLS BULLION TR by Precious Metals Bullion Trust

CPI Card Group Inc

PennyMac Mortgage Investment Trust 8.50% Senior Notes due 2028

PennyMac Mortgage Investment Trust 9.00% Senior Notes due 2030

PLAYMATES TOYS LTD ORD by Playmates Toys Ltd.

Playmates Toys Ltd

PennyMac Mortgage Investment Trust 8.125% Series A Fixed-to-Floating Rate Cumulative Redeemable Preferred Shares of Beneficial Interest

PennyMac Mortgage Investment Trust 8.00% Series B Fixed-to-Floating Rate Cumulative Redeemable Preferred Shares of Beneficial Interest

PennyMac Mortgage Investment Trust 6.75% Series C Cumulative Redeemable Preferred Shares of Beneficial Interest

PMV CONSUMER ACQ CORP A by PMV Consumer Acquisition Corp.

PMV CONSUMER ACQ A NEW by PMV Consumer Acquisition Corp.

PMV Consumer Acquisition Corp

PMV Consumer Acquisition Corp Warrants (31/08/2027)

PMV Pharmaceuticals Inc

PIMCO Municipal Income Fund III Common Shares of Beneficial Interest

PIMCO Municipal Income Fund III

SYNTARA LTD by SYNTARA LTD.

Primix Corp

Boab Metals Ltd

Philip Morris Intl's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) short percent of float has fallen 32.56% since its last report. The company recently reported that it has 8.98 million shares sold short, which is 0.58% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.49 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Philip Morris Intl Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744822828_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Philip Morris Intl has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Philip Morris Intl's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Philip Morris Intl's peer group average for short interest as a percentage of float is 2.90%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Philip Morris Intl?

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>UBS raised Mr. Cooper Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COOP#NASDAQ">COOP</a>) price target from $135 to $145. UBS analyst Douglas Harter maintained a Buy rating. Mr. Cooper shares closed at $114.39 on Tuesday. See how other analysts <a href="https://www.benzinga.com/quote/COOP/analyst-ratings">view this stock</a>.</li>
<li>Citigroup increased the price target for Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) from $163 to $180. Citigroup analyst Simon Hales maintained a Buy rating. Philip Morris shares closed at $160.09 on Tuesday. <a href="https://www.benzinga.com/quote/PM/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Stifel cut Marriott International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAR#NASDAQ">MAR</a>) price target from $295 to $240. Stifel analyst Simon Yarmak maintained a Hold rating. Marriott shares closed at $222.58 on Tuesday. See how other analysts <a href="https://www.benzinga.com/quote/MAR/analyst-ratings">view this stock</a>.</li>
<li>Barclays raised the price target for Interactive Brokers Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBKR#NASDAQ">IBKR</a>) from $188 to $193. Barclays analyst Benjamin Budish maintained an Overweight rating. Interactive Brokers shares closed at $173.43 on Tuesday. <a href="https://www.benzinga.com/quote/IBKR/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Keybanc cut the price target for Veeva Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) from $260 to $250. Keybanc analyst Sangita Jain maintained an Overweight rating. Veeva shares closed at $222.72 on Tuesday. See how other analysts <a href="https://www.benzinga.com/quote/VEEV/analyst-ratings">view this stock</a>.</li>
<li>JP Morgan slashed Annaly Capital Management, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NLY#NYSE">NLY</a>) price target from $21 to $19. JP Morgan analyst Richard Shane maintained an Overweight rating. Annaly Capital Management shares settled at $17.96 on Tuesday. <a href="https://www.benzinga.com/quote/NLY/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities cut Synopsys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) price target from $630 to $560. B of A Securities analyst Vivek Arya maintained a Buy rating. Synopsys shares closed at $425.65 on Tuesday. <a href="https://www.benzinga.com/quote/SNPS/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Canaccord Genuity slashed Fluence Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>) price target from $14 to $10. Canaccord Genuity analyst George Gianarikas maintained a Buy rating. Fluence Energy shares closed at $3.6750 on Tuesday.  <a href="https://www.benzinga.com/quote/FLNC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stephens &amp; Co cut the price target for Hancock Whitney Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWC#NASDAQ">HWC</a>) from $73 to $69. Stephens &amp; Co. analyst Matt Olney maintained an Overweight rating. Hancock Whitney shares settled at $48.69 on Tuesday. <a href="https://www.benzinga.com/quote/HWC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities slashed NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) price target from $200 to $160. B of A Securities analyst Vivek Arya maintained a Buy rating. Nvidia shares closed at $112.20 on Tuesday. <a href="https://www.benzinga.com/quote/NVDA/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying NVDA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="603" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16093856/image-1-3-1024x603.png" alt="" class="wp-image-874446" style="width:586px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16093856/image-1-3-1024x603.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16093856/image-1-3-300x177.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16093856/image-1-3-768x452.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/16093856/image-1-3.png 1097w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/04/44811698/jim-cramer-planet-fitness-is-doing-better-than-expected-says-no-to-this-industrial-stock">Jim Cramer: Planet Fitness Is Doing Better Than Expected, Says No To This Industrial Stock</a> </li>
</ul>
Photo via Shutterstock

Price Target

COOP

FLNC

IBKR

SNPS

VEEV

Nvidia To $160? Here Are 10 Top Analyst Forecasts For Wednesday

Citigroup analyst Simon Hales maintains Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) with a Buy and raises the price target from $163 to $180.

Citigroup Maintains Buy on Philip Morris Intl, Raises Price Target to $180

WIIM

BRBR

CASY

Coca-Cola European Partners plc Ordinary Shares

CCEP

COKE

FIZZ

PSMT

SISI

SMPL

Shares of several consumer staples stocks are trading higher. The sector may be moving up as investors gravitate towards more defensive assets following market-wide volatility and uncertainty.

Stifel analyst Matthew Smith maintains Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) with a Buy and raises the price target from $160 to $168.

Stifel Maintains Buy on Philip Morris Intl, Raises Price Target to $168

BofA Securities analysts Bryan D. Spillane, Lisa K. Lewandowski and Peter T. Galbo have put forward on Tuesday their research findings on consumer staple companies in the face of a potential recession.
The analysts said consumer staples have historically outperformed the S&amp;P 500 in most recent recessions, suggesting a defensive edge.
However, the analysts warned that current conditions, such as lingering high prices and weak volume growth, may limit their resilience in a future downturn.
Also Read: <a target="_blank" href="https://www.benzinga.com/tech/25/04/44695622/amazon-touts-ai-milestone-says-new-model-outshines-gpt-4o-in-real-time-speech" rel="noreferrer noopener">Amazon Touts AI Milestone, Says New Model Outshines GPT-4o In Real-Time Speech</a>
Still, their limited exposure to new tariffs could make the sector more appealing than others, potentially helping sustain valuation multiples.
During recessions, the Consumer Staples sector stock prices are primarily influenced by earnings per share (EPS) rather than sales growth.
Analysis shows that forward EPS estimates account for over 90% of stock price movement across key subsectors like Beverages, Household &amp; Personal Care (HPC), Packaged Food, and Tobacco, with the correlation being the tightest Beverages and HPC.
The analysts noted that this highlights the critical importance of earnings strength when evaluating stock performance in uncertain economic conditions.
A review of six past recessions reveals that certain Consumer Staples stocks consistently outperformed the S&amp;P 500.
Campbell Soup Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPB#NYSE">CPB</a>), Colgate-Palmolive Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>), General Mills Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIS#NYSE">GIS</a>), McCormick &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>), PepsiCo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>), and Hormel Foods Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HRL#NYSE">HRL</a>) each posted a 100% success rate in outperforming the index during those downturns.
In the last four recessions with the most comprehensive data, McCormick, General Mills, and Church &amp; Dwight Co. Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHD#NYSE">CHD</a>) delivered the strongest relative performance.
Top-performing Consumer Staples stocks in a potential downturn will likely share three traits: profit flexibility to offset revenue pressure and rising costs, strong U.S. manufacturing presence to limit tariff-related inflation, and solid balance sheets capable of sustaining share buybacks to boost earnings per share.
Analysts see McCormick, Coca-Cola Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>) and Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) as well-defended, with Keurig Dr Pepper Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDP#NASDAQ">KDP</a>), Molson Coors Beverage Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>) and Altria Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>) in the next tier of potential outperformers.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/25/04/44685643/whats-going-on-with-rocket-lab-stock-today-4" target="_blank" rel="noreferrer noopener">What&#8217;s Going On With Rocket Lab Stock Today?</a></li>
</ul>
Image via Shutterstock

This Beverage Maker, Tobacco Company And Packaged Food Giant Outshine In A Recession

Despite Wall Street continuing to tumble at the start of the second quarter of 2025, a small group of S&amp;P 500 stocks has remained nearly untouched by the chaos triggered by <a href="https://www.benzinga.com/topic/tariffs">Donald Trump's tariff policies.</a>
Stocks that delivered standout gains in the first quarter have held their ground through the opening week of the second quarter, showing resilience as the broader market sank under pressure from tariffs and softening earnings outlooks.
The five best-performing S&amp;P 500 names in Q1 2025 — CVS Health Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>), Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>), Newmont Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>), Cencora Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COR#NYSE">COR</a>) and Vertex Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) — have seen only minimal declines in recent days, defying a sharp 10% drop in the S&amp;P 500 index fueled by mounting trade tensions and concerns over recession. 
<h3 class="wp-block-heading">Quarterly Stars In A Cloudy Market</h3>
Let's break it down:
<ul>
<li>CVS Health soared 50.9% in Q1, posting its best quarterly gain since 1975. While the S&amp;P 500 dropped 10% in the first week of April, CVS is only down 5% in Q2.</li>
<li>Philip Morris jumped 31.9% last quarter, reaching multiple record highs and logging its second-best quarter since going public in 2008. PM is down 4.8% thus far in April.</li>
<li>Newmont rode the gold wave. With gold prices up 19%, the mining giant surged 29.7%, its strongest 3-month performance since early 2020. NEM fell 7.2% in Q2, yet showed a more contained drop than the broader market.</li>
<li>Cencora, formerly AmerisourceBergen, posted a 23.8% rise, and remains up 0.2% this month, dodging the tariff-driven downturn.</li>
<li>Vertex Pharmaceuticals climbed 21% in Q1, and has stayed flat so far in Q2, showing impressive stability in biotech.</li>
</ul>
<h3 class="wp-block-heading">But How Much More Room To Run?</h3>
Despite their impressive runs, future gains may be limited. Analyst consensus shows only Newmont and CVS have potential upside of 25.8% and 13.2%, respectively, based on median price targets. 
For the others, the path forward looks far less compelling. With valuations already stretched and macroeconomic risks mounting — from renewed trade tensions to signs of weakening corporate margins — the potential for further gains could quickly evaporate if analysts begin slashing forecasts in the coming weeks.
<figure class="wp-block-table is-style-stripes"> 
<table>
<thead>
<tr>
<th>Company</th>
<th>Q1 2025 Price Change</th>
<th>YTD Price Change</th>
<th>Median Target Upside</th>
</tr>
</thead>
<tbody>
<tr>
<td>CVS Health (CVS)</td>
<td>+50.9%</td>
<td>+43.71%</td>
<td>+13.16%</td>
</tr>
<tr>
<td>Philip Morris (PM)</td>
<td>+31.9%</td>
<td>+26.02%</td>
<td>+2.86%</td>
</tr>
<tr>
<td>Newmont Corporation (NEM)</td>
<td>+29.7%</td>
<td>+21.77%</td>
<td>+25.77%</td>
</tr>
<tr>
<td>Cencora Inc. (COR)</td>
<td>+23.8%</td>
<td>+23.78%</td>
<td>+0.68%</td>
</tr>
<tr>
<td>Vertex Pharmaceuticals (VRTX)</td>
<td>+21.0%</td>
<td>+19.20%</td>
<td>+6.66%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Data as of April 7, 2025</figcaption></figure>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44667104/speculators-raise-wagers-on-fed-emergency-rate-cuts-as-theories-of-self-induced-crash-gather-pace">Emergency Fed Rate Cut Odds Spike As Trump Says &#8216;No Inflation,&#8217; Calls for Immediate Action</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

These 5 S&P 500 Winners Held Strong In Q1 — Can The Rally Continue?

Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) has outperformed the market over the past 5 years by 1.12% on an annualized basis producing an average annual return of 16.54%. Currently, Philip Morris Intl has a market capitalization of $249.35 billion. 
Buying $1000 In PM: If an investor had bought $1000 of PM stock 5 years ago, it would be worth $2,116.77 today based on a price of $160.20 for PM at the time of writing.
<h3>Philip Morris Intl's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743691558_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

The S&amp;P 500 Index just finished a vicious <a href="https://www.benzinga.com/topic/s-p-500">first quarter of 2025</a>.
The stock market index lost over 4.5% as investor sentiment, as indicated by the CNN Money Fear and Greed Index, languishes in the <a href="https://www.benzinga.com/25/04/44601155/sp-500-settles-higher-ahead-of-tariff-day-fear-greed-index-remains-in-extreme-fear-zone">&#8220;Extreme Fear&#8221; category</a>. 
The widely held SPX fell into correction territory earlier this week, indicating a 10% drop from its recent high, before regaining some ground.
Also Read: <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/03/44547975/sticky-inflation-weighs-on-markets-spy-qqq-tech-stocks-take-a-hit">Sticky Inflation Weighs On Markets — SPY, QQQ, Tech Stocks Take A Hit</a>
As one of the most widely used proxies for the SPX, the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) fell 3.76% this year as of writing. However, <a href="https://www.benzinga.com/etfs">in the ETF</a>, some stocks defied the trend:
<ul>
<li>CVS Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) jumped 53.35% due to robust earnings growth in the last quarter. </li>
<li>Gold miner Newmont Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>) rose 26.21%, and </li>
<li>Philip Morris International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) spiked 29% as it shifted its focus to smoke-free products.</li>
</ul>
Also Read: <a href="https://www.benzinga.com/trading-ideas/25/04/44597684/exclusive-marchs-20-most-searched-tickers-on-benzinga-pro-where-do-tesla-nvidia-apple-applovin-stock-rank">EXCLUSIVE &#8211; March&#8217;s 20 Most-Searched Tickers On Benzinga Pro — Where Do Tesla, Nvidia, Apple, Applovin Stock Rank?</a>
Markets are gearing up for even more turbulence as President Donald Trump unveiled a comprehensive slate of tariffs. Watch the stream below.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="&#x1f534;WATCH LIVE: Trump Speaks Live From The White House on Liberation Day &#x7C; April 2nd, 2025" width="500" height="281" src="https://www.youtube.com/embed/wgmKYg-zK9o?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Investors worry that these tariffs, potentially imposed widely on trading partners from China to Mexico and Canada, will raise costs, restrict consumer purchases, and temper economic growth. 
With economic news, Federal Reserve actions, and geopolitical tensions front and center, the SPX continues on uncertain footing. 
Investors will closely monitor how the market responds to Trump&#8217;s tariff declaration and whether defensive sectors continue to outperform in an increasingly uncertain economic climate.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/specialty-etfs/25/04/44613351/chipotles-stock-is-sizzling-bill-ackman-loves-it-and-these-etfs-do-too">Chipotle&#8217;s Stock Is Sizzling—Bill Ackman Loves It And These ETFs Do Too</a></li>
</ul>
Image: Shutterstock

Broad U.S. Equity ETFs

ETFs

SPX Nosedives 4.5%: Can ETFs Like SPY Weather The Market Storm?

Deep-pocketed investors have adopted a bearish approach towards Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in PM usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 15 extraordinary options activities for Philip Morris Intl. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 26% leaning bullish and 53% bearish. Among these notable options, 13 are puts, totaling $944,250, and 2 are calls, amounting to $113,007.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $135.0 to $175.0 for Philip Morris Intl over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Philip Morris Intl's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Philip Morris Intl's significant trades, within a strike price range of $135.0 to $175.0, over the past month.
<h3>Philip Morris Intl Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742832933_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$14.3</td>
<td>$14.2</td>
<td>$14.3</td>
<td>$165.00</td>
<td>$110.1K</td>
<td align="right">220</td>
<td align="right">154</td>
</tr>
<tr>
<td>PM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$14.5</td>
<td>$14.2</td>
<td>$14.1</td>
<td>$165.00</td>
<td>$108.7K</td>
<td align="right">220</td>
<td align="right">77</td>
</tr>
<tr>
<td>PM</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$18.8</td>
<td>$18.4</td>
<td>$18.61</td>
<td>$170.00</td>
<td>$104.2K</td>
<td align="right">142</td>
<td align="right">56</td>
</tr>
<tr>
<td>PM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$14.0</td>
<td>$13.7</td>
<td>$14.0</td>
<td>$165.00</td>
<td>$100.8K</td>
<td align="right">0</td>
<td align="right">72</td>
</tr>
<tr>
<td>PM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$10.0</td>
<td>$9.8</td>
<td>$10.0</td>
<td>$160.00</td>
<td>$99.0K</td>
<td align="right">0</td>
<td align="right">299</td>
</tr>
</tbody>
</table>

<h3>About Philip Morris Intl</h3>
Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heatsticks, vapes, and oral nicotine offerings primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI has not only diversified away from smokeable products but also gained a toehold into the US to sell its iQOS heated tobacco product.
<h3>Where Is Philip Morris Intl Standing Right Now?</h3>
<ul>
<li>With a volume of 1,329,602, the price of PM is down -0.03% at $151.43. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 30 days.</li>
</ul>
<h3>Professional Analyst Ratings for Philip Morris Intl</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $175.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Overweight rating on Philip Morris Intl with a target price of $175. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Philip Morris Intl options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Comments

Philip Morris Intl

뉴스

에 대한 최신 뉴스 Philip Morris Intl (NYSE:PM) 주식

화요일, 4월 08, 2025

월요일, 4월 07, 2025

화요일, 3월 04, 2025

토요일, 10월 26, 2024

수요일, 10월 23, 2024

일요일, 7월 21, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌